Altre lingue Baxter International Inc.

Azioni

BAX

US0718131099

Mercato chiuso - Nyse Altri mercati azionari 22:00:01 22/04/2024			Variaz. 5gg	Var. 1 gen.
40,4 ^USD	+2,36%		+0,90%	+4,50%

11/04	Baxter International Inc. espande il portafoglio farmaceutico con nuovi prodotti iniettabili negli Stati Uniti	CI
04/04	Pfizer, Baxter, Thermo Fisher, altre FTC sono state avvertite di prolungare il periodo di revisione delle fusioni	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Edwards Lifesciences Corporation : L’histoire se poursuit	10:36
Exact Sciences Names Aaron Bloomer CFO	15/04
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.	11/04
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S	11/04
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors	10/04
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	04/04
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump	01/04
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01/04
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01/04
Baxter International : 2023 Proxy Statement Supplement	28/03
Baxter to Host Annual Meeting of Stockholders in Virtual Format	27/03
Baxter International Files Definitive Proxy Statement with Securities and Exchange Commission	25/03
Baxter International Inc. Enters into Fourth Amendment to the Existing $4.0 Billion Term Loan Credit Facility	21/03
Baxter International Receives a Shareholder Proposal from John Chevedden	14/03
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data	05/03
Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors	05/03
Dialysis firms gain as Ozempic kidney trial data disappoints	05/03
Baxter International Provides an Update on the Planned Separation of its Kidney Care Business	04/03
Baxter International to Present at Raymond James 45th Annual Institutional Investors Conference	01/03
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference	29/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Baxter International Inc.

Azioni

BAX

US0718131099

Altre lingue

Filtri